Sign in
Taking peopleNo phase

Bedside chest scan to detect and monitor sudden lung blood clots

Tests a bedside, radiation-free chest scan for acute pulmonary embolism in adults.

Key facts

Who runs it
Beijing Tsinghua Chang Gung Hospital
Where
China4 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism
Status
Recruiting
People taking part
275 people, planned
Started
2 Jan 2026
Expected to end
30 Dec 2028
Type of study
Observational, 4 groups
Treatments tested
  • Pulsatile Electrical Impedance Tomography
Record updated
4 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with acute pulmonary embolism (a sudden blood clot in the lungs) confirmed by a CT scan of the lung arteries. It also takes people suspected of having one in whom it was not found, and healthy controls. It tests a bedside lung scan without radiation called pulsatile electrical impedance tomography (EIT).

Age
18 years or older
Sex
All sexes
Disease stage
Acute pulmonary embolism confirmed by CT pulmonary angiography, newly diagnosed for the prospective part. Control groups: people suspected of having it in whom it was not confirmed, and healthy adults.
Biomarker or test result
Healthy controls must have normal D-dimer levels (a blood clot test) and a simplified Wells score ≤1. Prospective patients must have a body mass index less than 50 kg/m².

Main reasons for not taking part

  • Earlier diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension
  • Sudden worsening of COPD, acute heart failure, heart attack or other severe heart or lung disease
  • Pregnancy or breastfeeding
  • Chest deformity, or anything that blocks the EIT electrode belt, such as an implanted defibrillator, chest wounds or implanted pumps
  • Unstable condition needing emergency rescue, or taking part in another clinical trial at the same time (prospective part)

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Adults aged 18 years or older. For retrospective PE cases: patients with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination, adequate image data, and available clinical information; For retrospective healthy controls: adults without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history; For prospective PE patients: patients newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, with body mass index less than 50 kg/m², who voluntarily participate and provide written informed consent; For prospective non-PE controls: patients with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed, who voluntarily participate and provide written informed consent

Who cannot take part

  • Previous diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension; Acute exacerbation of chronic obstructive pulmonary disease, acute heart failure, acute myocardial infarction, or other severe cardiopulmonary diseases that may interfere with study assessment; Pregnancy or lactation. Thoracic deformity. Contraindications to EIT examination, including automatic implantable cardioverter defibrillator, chest wounds limiting electrode belt placement, implanted pumps, or other conditions unsuitable for EIT electrode belt placement; Participation in another clinical trial during the same period, for prospective participants; Unstable vital signs requiring emergency rescue, leaving no time to complete EIT examination, for prospective participants; Any other condition considered unsuitable for participation by the investigators

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This multicenter observational diagnostic study aims to evaluate pulsatile electrical impedance tomography (EIT) for the diagnosis and monitoring of acute pulmonary embolism. The study includes a retrospective phase and a prospective phase. EIT-derived ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index will be compared with CT pulmonary angiography and relevant clinical indicators. The study is designed to assess whether EIT can provide a noninvasive, bedside, radiation-free method for pulmonary embolism diagnosis, risk stratification, and dynamic treatment monitoring.

The 4 groups in the trial

  • Retrospective PE Cases

    Patients aged 18 years or older with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination and available clinical data in the retrospective phase.

    Treatment: Pulsatile Electrical Impedance Tomography

  • Retrospective Healthy Controls

    Adults in the retrospective phase without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.

    Treatment: Pulsatile Electrical Impedance Tomography

  • Prospective PE Patients

    Patients aged 18 years or older newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, who voluntarily participate and provide written informed consent.

    Treatment: Pulsatile Electrical Impedance Tomography

  • Prospective Non-PE Controls

    Patients aged 18 years or older with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed. These participants voluntarily participate and provide written informed consent in the prospective phase.

    Treatment: Pulsatile Electrical Impedance Tomography

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Retrospective and Prospective Diagnostic Observational Study of Pulsatile Electrical Impedance Tomography for Diagnosis, Risk Stratification, and Dynamic Monitoring of Acute Pulmonary Embolism
Plain-language title
Bedside chest scan to detect and monitor sudden lung blood clotsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
4 August 2026